![Beth Hoffman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: - $ as of 30/06/2026
Beth J.
Hoffman is the founder of Origami Therapeutics, Inc., founded in 2015, where the title held is President & Chief Executive Officer.
Dr. Hoffman currently holds the position of Independent Director at Biofrontera, Inc., starting in 2015.
Dr. Hoffman earned a doctorate degree from The Johns Hopkins University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOFRONTERA, INC. -.--% | 04/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| BIOFRONTERA INC. | Director/Board Member | 03/03/2015 |
Origami Therapeutics, Inc.
 Origami Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical-stage biopharmaceutical company | Chief Executive Officer | 01/01/2015 |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biofrontera, Inc.
 Biofrontera, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes dermatological drugs | Health Technology |
Origami Therapeutics, Inc.
Origami Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical-stage biopharmaceutical company | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
